Propane

Propane

SCHEMBL1389491

CCC.CCC(C)CCC=O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
TSHR P16473 3/20 0.38
TDP1 Q9NUW8 2/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.32
FAAH O00519 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TRPV1 Q8NER1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10146424 0.97
SCHEMBL5160007 0.97
SCHEMBL261739 0.97
Ethane SCHEMBL27996829 0.95 ALDH1A1 (0.41) ALDH1A1TSHRTDP1MAPK1HIF1A
SCHEMBL1781867 0.92 ALDH1A1 (0.39) ALDH1A1TSHRTDP1MAPK1HIF1A
SCHEMBL1301758 0.88 TSHR (0.39) ALDH1A1TSHRHIF1AFAAHSMN1; SMN2
SCHEMBL1300977 0.88 TSHR (0.39) ALDH1A1TSHRHIF1AFAAHSMN1; SMN2
SCHEMBL8811536 0.88 TSHR (0.39) ALDH1A1TSHRHIF1AFAAHSMN1; SMN2
SCHEMBL592086 0.88 TSHR (0.39) ALDH1A1TSHRHIF1AFAAHSMN1; SMN2
SCHEMBL1786594 0.85 ALDH1A1 (0.38) ALDH1A1TSHRTDP1MAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673332-B1 HYDROFORMYLATION OF BUTENES COMPRISING ISOBUTYLENE EXXONMOBIL CHEM PATENTS INC (US) 2015-06-17 EP claimed
US-8921607-B2 Hydroformylation of butenes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-12-30 US claimed
US-20120253059-A1 Hydroformylation Of Butenes EXXONMOBIL CHEMICAL PATENTS INC. 2012-10-04 US claimed
US-20120010426-A1 Processes Related to the Hydroformylation of Butenes EXXONMOBIL CHEMICAL PATENTS INC. 2012-01-12 US claimed
US-20110137071-A1 Processes Related To The Hydroformylation Of Butenes EXXONMOBIL CHEMICAL PATENTS INC. 2011-06-09 US claimed
US-20070112220-A1 Hydroformylation of butenes comprising isobutylene EXXONMOBIL CHEMICAL PATENTS INC. 2007-05-17 US claimed
EP-1673332-A1 HYDROFORMYLATION OF BUTENES COMPRISING ISOBUTYLENE ExxonMobil Chemical Patents Inc. (US) 2006-06-28 EP claimed
WO-2005028407-A1 HYDROFORMYLATION OF BUTENES COMPRISING ISOBUTYLENE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-03-31 WO claimed
EP-1673332-B1 HYDROFORMYLATION OF BUTENES COMPRISING ISOBUTYLENE EXXONMOBIL CHEM PATENTS INC (US) 2015-06-17 EP disclosed
US-8921607-B2 Hydroformylation of butenes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-12-30 US disclosed
US-20120253059-A1 Hydroformylation Of Butenes EXXONMOBIL CHEMICAL PATENTS INC. 2012-10-04 US disclosed
US-8178730-B2 Processes related to the hydroformylation of butenes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2012-05-15 US disclosed
US-20120010426-A1 Processes Related to the Hydroformylation of Butenes EXXONMOBIL CHEMICAL PATENTS INC. 2012-01-12 US disclosed
US-8049043-B2 Processes related to the hydroformylation of butenes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-11-01 US disclosed
US-8022256-B2 Hydroformylation of butenes comprising isobutylene EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-09-20 US disclosed
US-20110137071-A1 Processes Related To The Hydroformylation Of Butenes EXXONMOBIL CHEMICAL PATENTS INC. 2011-06-09 US disclosed
US-20070112220-A1 Hydroformylation of butenes comprising isobutylene EXXONMOBIL CHEMICAL PATENTS INC. 2007-05-17 US disclosed
EP-1673332-A1 HYDROFORMYLATION OF BUTENES COMPRISING ISOBUTYLENE ExxonMobil Chemical Patents Inc. (US) 2006-06-28 EP disclosed
WO-2005028407-A1 HYDROFORMYLATION OF BUTENES COMPRISING ISOBUTYLENE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120253059-A1 Hydroformylation Of Butenes HMOX2, BBOX1, HMOX1 ALDH1A1 53/4885TSHR 4874/4885TDP1 1653/4885
US-20120010426-A1 Processes Related to the Hydroformylation of Butenes GRHPR, BLVRB, DHPS ALDH1A1 37/4885TSHR 4871/4885TDP1 1424/4885
US-20070112220-A1 Hydroformylation of butenes comprising isobutylene HMOX2, BBOX1, HMOX1 ALDH1A1 81/4885TSHR 4884/4885TDP1 1650/4885
US-20110137071-A1 Processes Related To The Hydroformylation Of Butenes GRHPR, BLVRB, DHPS ALDH1A1 37/4885TSHR 4871/4885TDP1 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.